BSMA Presents A Virtual Mini-Conference:  CELL & GENE THERAPY TRANSFORM OF BIOTECH

THEME:  “COMMERCIALIZATION OF CELL & GENE THERAPY: ADVANCING TECHNOLOGY AND INNOVATION”

BSMA, the premiere global alliance of supply chain management professionals in Life Sciences, is bringing together the stakeholders of the embryonic Cell and Gene Therapy to confront its formidable challenge of commercialization.

The innovative therapy of Cell and Gene Therapy has imposed Draconian demands on the supply chain in terms of production batch of one, sixteen-day vein to vein lead time, cryogenic preservation and cold-chain logistics, chain of custody, real-time patient care, and prohibitive cost of treatment. Executives of CGT companies and service providers will address the “Issues and Answers” of raw material supply, supplier QA, apheresis, scale out of clinical and manufacturing operations, distribution and logistics, information systems, governmental compliance and efficacy of treatment.